Inhaled Triple Therapy with Extrafine Single Inhaler Versus Multiple Devices in Chronic Obstructive Pulmonary Disease (TRIPOLI): A Post-Authorization Retrospective Study [0.03%]
慢性阻塞性肺疾病患者使用超微单剂量吸入三联药与多种装置的多剂量吸入药物治疗的回顾性研究（TRIPOLI）
Eva Cabrera César,Javier López García,Daniel Enrique Vega Lizarazo et al.
Eva Cabrera César et al.
Background: Triple therapy significantly enhances both clinical and functional outcomes in patients with uncontrolled chronic obstructive pulmonary disease (COPD), even when they are already receiving treatment. However, ...
Clinical Pharmacokinetics of Inhaled Drugs for Pulmonary Hypertension [0.03%]
用于治疗肺动脉高压的吸入药物的临床药代动力学
Yu Lin,Yuanqi Su,Zhongjie Cheng et al.
Yu Lin et al.
Pulmonary hypertension (PH) is a serious condition characterized by elevated blood pressure in the pulmonary arteries. Current treatment approaches mainly focus on using vasodilator agents to reduce pulmonary blood pressure and improve bloo...
Polycomponent metal-organic frameworks of substituent polydispersion hydroxypropyl-β-cyclodextrin as inhalable drug carrier [0.03%]
分支代数多分散羟丙基-β-环糊精金属有机骨架作为吸入药物载体
Xiaojian He,Huipeng Xu,Xiangyu Zhao et al.
Xiaojian He et al.
Cyclodextrin metal-organic frameworks (CD-MOFs) have garnered considerable attention for their unique porous structure, outstanding properties and diverse pharmaceutical applications. To date, all reported CD-MOFs have been synthesized usin...
Effect of Gamification on Improved Adherence to Inhaled Medications in Chronic Obstructive Pulmonary Disease: Randomized Controlled Trial [0.03%]
游戏化对慢性阻塞性肺疾病吸入药物治疗依从性改善的效果：随机对照试验
Xiting Huang,Zhili Jiang,Yifan Dai et al.
Xiting Huang et al.
Background: Inhaled medication is the preferred route of administration for patients with chronic obstructive pulmonary disease (COPD). The compliance rate of inhaled medication in patients with COPD is
Randomized Controlled Trial
Journal of medical Internet research. 2025 May 14:27:e65309. DOI:10.2196/65309 2025
Guido Schmiemann,Michael Dörks,Christian Grah;Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin (DEGAM) et al.
Guido Schmiemann et al.
The aim of the guideline on climate-conscious prescribing of inhaled medicines is to reduce the carbon footprint of the healthcare system. Chronic respiratory diseases such as asthma and COPD are at risk by climate change. At the same time ...
High Anxiety in COPD: A Barrier to Effective Inhaler Medication Adherence and Disease Management [0.03%]
慢性阻塞性肺疾病高焦虑：有效吸入药物依从而及疾病管理的障碍
Meijia Chen,Zhaoqian Gong,Junrao Wang et al.
Meijia Chen et al.
Aims and objective: To explore the heterogeneity of disease-specific anxiety profiles among patients with chronic obstructive pulmonary disease (COPD) using latent profile analysis (LPA), and to identify the associations ...
Investigation of the Suitability of Utilizing Plasma Concentration as a Surrogate to Understand Lung Exposure of Inhaled Drug in Rats: Different Delivery Methods of Fluticasone Propionate [0.03%]
基于大鼠的吸入给药的不同投与方法，调查血浆浓度作为理解肺暴露药物替代指标的适用性：氟替卡松磷酸氢二钠
Po-Chang Chiang,Cornelia H Rinderknecht,Jia Liu et al.
Po-Chang Chiang et al.
Pulmonary diseases, such as asthma and chronic obstructive pulmonary disease (COPD) are complex human airway diseases that affect millions of people worldwide. A topical drug delivery system such as a dry powder inhaler (DPI) is often used ...
An In Vitro Dissolution Method for Inhaled Drugs Depositing in the Tracheobronchial Lung Region [0.03%]
一种测定气道肺部沉积吸入药物的体外溶出方法研究
Alexander Huang,Scott Tavernini,Dino J Farina et al.
Alexander Huang et al.
Purpose: To evaluate and develop a novel dissolution test method using tracheobronchial (TB) mimic filters for assessing the dissolution behavior of inhaled drugs targeting the tracheobronchial lung region. ...
François Maltais,Andréanne Côté
François Maltais
A survey and analysis of inhalation medication adherence among 977 COPD patients in a region of northern China [0.03%]
中国北方地区977例慢性阻塞性肺疾病患者吸入药物依从性调查与分析
Lu Liu,Jinling Xiao,Shihuan Yu
Lu Liu
Objective: Inhalation therapy is recommended by the World Health Organization as the first-line treatment for chronic obstructive pulmonary disease (COPD) due to its rapid onset of action, good safety profile, ease of use...
耗时 0.19976 秒，为您在
48206918
条记录里面共找到 601 篇文章 [XML]